I disagree with you on this one. Neuren made an excellent deal.
"The two companies will jointly share global research, development and commercialization responsibilities and share 50/50 in all worldwide costs and future profits." <- Neuren has the ROW rights for Trof which equals more income than the 60 million upfront payment and potential milestone payments of up to $907 million and royalties on future sales
I personally think Acadia learned its lesson from the deal they made with NEU and secure them more rights in future deals which they have achieved. Plus they have secured a 2nd compound (the undisclosed one), which again they didnt do with Neuren. Otherwise they would have aimed at NZZ 2591 already.
my opinion only ...
- Forums
- ASX - By Stock
- ACADIA PARTNERSHIP STOKE THERAPEUTICS
I disagree with you on this one. Neuren made an excellent deal....
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.07 |
Change
-0.200(1.31%) |
Mkt cap ! $1.921B |
Open | High | Low | Value | Volume |
$15.38 | $15.47 | $14.99 | $1.856M | 122.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 423 | $15.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.07 | 333 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 390 | 15.060 |
2 | 1251 | 15.050 |
4 | 721 | 15.040 |
2 | 336 | 15.030 |
3 | 580 | 15.020 |
Price($) | Vol. | No. |
---|---|---|
15.070 | 172 | 5 |
15.080 | 345 | 9 |
15.090 | 368 | 4 |
15.100 | 704 | 6 |
15.110 | 400 | 3 |
Last trade - 11.23am 30/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |